Bessemer Group’s Sutro Biopharma STRO Stock Holding History

Bessemer Group’s Portfolio STRO Stock Details STRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,820	Closed	-$374K	–	1641
2020 Q2	$374K	Buy	+4,820	New	+$463K	﹤0.01%	1034

Other funds holding STRO

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bessemer Group's STRO Position: Q3 2020 in Review

Bessemer Group sold out of Sutro Biopharma (STRO) in Q3 2020, closing a stake of 4,820 shares — an estimated $374K sold.

Bessemer Group first reported a position in STRO in Q2 2020 and held it in 1 quarter. The position peaked at $374K in Q2 2020. 86 funds tracked by Wall St. Rank hold STRO as of Q3 2020.

Bessemer Group reported no remaining Sutro Biopharma position as of Q3 2020 after selling out during the quarter.
Bessemer Group sold 4,820 Sutro Biopharma shares in Q3 2020, an estimated $374K.
Bessemer Group first reported a position in Sutro Biopharma in Q2 2020 and held it in 1 quarter.
Bessemer Group's Sutro Biopharma position peaked at $374K in Q2 2020.
86 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2020.

Based on Bessemer Group's 13F filing for Q3 2020, filed 12 Nov 2020.